Patent details

Basic Information

Publication number:

EP1275383

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP020121844

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Modified release pharmaceutical composition containing Bupropion HCI as active substance

French Title of Invention:

Composition pharmaceutique à libération contrôlée contenant du bupropion-HCl en tant qu'agent actif

German Title of Invention:

Formulierung mit gesteuerter Wirkstoffabgabe enthaltend Bupropion-HCI als Wirkstoff

SPC Number:

Dates

Filing date:

03/06/2002

Grant date:

31/03/2004

EP Publication Date:

31/03/2004

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/01/2003

EP B1 Publication Date:

31/03/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/06/2004

Expiration date:

03/06/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/06/2002

 

 

Name:

Valpharma S.A.

Address:

Via Ranco, 112, 47899 Serravalle, San Marino (SM)

Inventor

1

Name:

Valducci Roberto

Address:

Italy (IT)

2

Name:

Alighieri Tiziano

Address:

Italy (IT)

3

Name:

Avanessian Serozh

Address:

Italy (IT)

Priority

Priority Number:

MI20011457

Priority Date:

09/07/2001

Priority Country:

Italy (IT)

Classification

Main IPC Class:

A61K 31/135;

Filing date	Document type	Number of pages